Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013
10.5415/apallergy.2016.6.1.43
- Author:
Oki SUWARSA
1
;
Wulan YUWITA
;
Hartati Purbo DHARMADJI
;
Endang SUTEDJA
Author Information
1. Division of Allergy-Immunology, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran
- Publication Type:Original Article
- Keywords:
Corticosteroid Treatment;
Stevens-Johnson Syndrome;
Toxic Epidermal Necrolysis
- MeSH:
Acetaminophen;
Adrenal Cortex Hormones;
Amoxicillin;
Carbamazepine;
Hospitals, General;
Humans;
Ibuprofen;
Indonesia;
Male;
Mortality;
Public Health;
Respiratory Insufficiency;
Retrospective Studies;
Rifampin;
Sepsis;
Stevens-Johnson Syndrome;
Trihexyphenidyl
- From:
Asia Pacific Allergy
2016;6(1):43-47
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCAR) with high mortality and have a significant public health impact because of high mortality and morbidity. OBJECTIVE: To describe data the epidemiological features, etiology, and treatment of retrospectively reviewed data of all patients with SJS and TEN. METHODS: Retrospective study was conducted in patients with SJS and TEN treated from January 1, 2009 to December 31, 2013 in Dr. Hasan Sadikin General Hospital Bandung, Indonesia. RESULTS: A total of 57 patients were enrolled in the study. Thirty-nine cases of SJS (21 males and 18 females), 7 cases of SJS overlapping TEN (4 males and 3 females), and 11 cases of TEN (5 males and 6 females) were reported. All cases of SJS and TEN were caused by drugs, such as paracetamol (16.56%), carbamazepine (7%), amoxicillin (5.73%), ibuprofen (4.46%), rifampicin (3.18%), and trihexyphenidyl (3.18%). All cases were treated systemically with corticosteroid alone (100%). Seven from 57 patients (12,28%) died; 5 cases developed sepsis and 2 cases developed respiratory failure. The mortality rate was 7.69% in SJS, 0% in SJS/TEN overlap, and 36.36% in TEN. CONCLUSION: The role of systemic corticosteroids in SJS and TEN are still controversial, but with a prompt and earlier treatment reduces mortality and improves outcomes of SJS and TEN patients.
